介绍ISPA-AD:对于阿尔茨海默病的交互式社会问题解决评估
Claire Maussire1, Mohamad El Haj1, Etienne Emmelin2
1Laboratory of Psychology of the Pays de la Loire, LPPL, UR 4638, Nantes University, University of Angers, Nantes, France.
Journal of neuropsychology
|January 28, 2026
概括
在阿尔茨海默病 (AD) 患者的社会适应方面遇到的困难,使用新的阿尔茨海默病交互式社会问题解决评估 (ISPA-AD) 进行了探索. 该工具有效地确定了阿兹海默症患者的社会问题解决缺陷.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 中的社会适应挑战与社会认知受损有关,例如思想理论和情感识别.
- 社会问题解决 (SPS) 是AD相关社会缺陷的一个研究不足但关键因素.
研究的目的:
- 开发和评估阿尔茨海默病的交互式社会问题解决评估 (ISPA-AD),这是一个评估阿尔茨海默病SPS的新工具.
- 调查ISPA-AD. 的心理测量特性和辨别能力.
主要方法:
- 开发ISPA-AD,包括交互式场景来评估口头和非口头SPS组件.
- 41名参与者的探索性评估 (19名阿尔茨海默病患者,22名健康对照).
- 心理测量分析包括内部一致性,构造有效性和辨别能力.
主要成果:
- ISPA-AD表现出良好的内部一致性 (α = .811) 和强大的构造有效性.
- 该工具在区分AD患者与对照患者方面表现出极好的准确性 (AUC = .906).
- 阿尔茨海默病患者在SPS任务上表现明显差,表明了特定的缺陷模式.
结论:
- ISPA-AD提供了一种新的,生态相关的方法来评估阿尔茨海默病中的SPS.
- 初步发现支持ISPA-AD的临床实用性,以了解AD的社会认知机制.
- 建议在更大,多样化的样本和可靠性研究中进行进一步的验证.
相关概念视频
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:19Autism Spectrum Disorder
2.0K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
2.0K
01:29Alzheimer Disease l: Introduction
29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29